BlackRock Health Sciences Term Trust (BMEZ) Fund Overview
BlackRock Health Sciences Term Trust (BMEZ) — price $15.92 (-3.05%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
BlackRock Health Sciences Term Trust · BMEZ
BlackRock Health Sciences Trust II is a closed-end management investment company focused on total return and income through investments in the health sciences sector. The company aims to deliver a combination of current income, current gains, and long-term capital appreciation.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $15.92 |
| Change on the day | -3.05% |
| Price / earnings (trailing) | 9.40 |
| Shares traded on the day | 211.5K |
Price & events
Other perspectives
Council score for BlackRock Health Sciences Term Trust (BMEZ): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: May 2, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On May 2, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is BlackRock Health Sciences Term Trust (BMEZ), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. BlackRock Health Sciences Term Trust (BMEZ) is the company analyzed here. In Q4 FY2024 it reported revenue of $24M and net income of -$22M.
What do the latest results show for BlackRock Health Sciences Term Trust (BMEZ)?
Short answer · as of
The most recent reported quarter, Q4 FY2024, carried revenue of $24M.
Quarterly income statement — 1 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2024 | $24M | -$22M | -$1.53 (diluted) |
What are the financial strengths and risks for BlackRock Health Sciences Term Trust (BMEZ)?
Short answer · as of
The distress and quality screens read Piotroski F 6. Trailing ratios: ROE 3.5% · ROA 3.0% · earnings yield 9.9% · free-cash-flow yield 3.6%.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 3
- Purchases
- 0
- Sales
- 1
- Other transactions
- 11
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held BMEZ in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported BMEZ in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about BlackRock Health Sciences Term Trust (BMEZ)?
Investor Questions: BMEZ Stock
These answers are editorial: 1 of these 1 answer is drawn from the BMEZ research dossier (written Mar 16, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What are the main risks for BMEZ?
The main risks for BlackRock Health Sciences Trust II include market volatility, regulatory changes affecting the healthcare industry, and increased competition from other asset management firms. As a closed-end fund, BMEZ is also subject to the risk of trading at a discount to its net asset value (NAV).
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 11 figures on this page — 9 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com